Glucagon Receptor

Inhibitory Selectivity

Glucagon Receptor Products

Catalog No. Information Product Use Citations Product Validations
S0555New

Adomeglivant

Adomeglivant (LY2409021) is a potent and selective antagonist of glucagon receptor that is used as a chronic treatment for type 2 diabetes.

S9697New

Semaglutide

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).

S8517

Lixisenatide

Lixisenatide is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies.

S9307

Shanzhiside methyl ester

Shanzhiside methylester is a principle effective iridoid glycoside of L. rotata and serves as a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist.

S8256

Liraglutide

Liraglutide (Victoza, Liraglutida, Liraglutidum, NN2211) is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.

S3734

Albiglutide Fragment

Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).

Catalog No. Information Product Use Citations Product Validations
S0555New

Adomeglivant

Adomeglivant (LY2409021) is a potent and selective antagonist of glucagon receptor that is used as a chronic treatment for type 2 diabetes.

Catalog No. Information Product Use Citations Product Validations
S9697New

Semaglutide

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).

S8517

Lixisenatide

Lixisenatide is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies.

S9307

Shanzhiside methyl ester

Shanzhiside methylester is a principle effective iridoid glycoside of L. rotata and serves as a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist.

S8256

Liraglutide

Liraglutide (Victoza, Liraglutida, Liraglutidum, NN2211) is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.

Catalog No. Information Product Use Citations Product Validations
S3734

Albiglutide Fragment

Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).

Tags: Glucagon Receptor antagonist | Glucagon Receptor agonist | Glucagon Receptor Inhibition| Glucagon Receptor Activation| Glucagon Receptor antagonist | Glucagon Receptor agonist | Glucagon Receptor Activity